The Native Antigen Company expands – Press Release May 2017

May 1st, 2017

The Native Antigen Company expands into new development and production facilities and introduces new services Expansion doubles manufacturing capacity New assay development facilities New suite of services includes immunoassay development  Oxford, UK, 2nd May 2017: The Native Antigen Company (NAC) announced today that it has relocated into larger facilities, in Oxfordshire, UK. The new building […]

Langford Locks services

We’re expanding to meet demand and to offer new services

April 29th, 2017

We are moving to new facilities to meet rapidly growing demand for products and services We are pleased to announce that The Native Antigen Company is moving to new, expanded bespoke facilities with effect from April 27th. 2017 These new facilities will enable us to meet the rapidly increasing demand for our products and services […]

Antibodies from The Native Antigen Company

April 19th, 2017

Antibodies are used in a wide range of research applications and immunodiagnostic assays. The reliability, reproducibility and sensitivity of an antibody is key to the success of any antibody based application and there is an increasing demand for high quality antibodies for both research and diagnostic assay development. The Native Antigen Company already has an […]

Silver-lining from zika

A silver-lining from Zika virus?

September 12th, 2017

Zika virus (ZIKV) is an enveloped single stranded RNA virus. It is a member of the Flavivirus genus of the family Flaviviridae, which is transmitted to humans primarily through the bite of the Aedes aegypti mosquito. In 2015, a major outbreak of Zika virus was associated with cases of foetal microcephaly and Guillain-Barre syndrome in […]

Oxford Emerging Viruses Conference 2017

July 24th, 2017

The Native Antigen Company are pleased to announce their support as Gold Sponsors for the Emerging Viruses 2017 symposium in Oxford on September 4th-5th. This event features a great line-up of speakers with a compelling agenda, and will be of interest to anyone working in virology and infectious disease.  Full details can be found on the […]

Mutation in Zika NS1 linked to recent epidemic

July 20th, 2017

Until recently, cases of reported Zika virus infection were very few and the disease was described as a mild self-limiting febrile illness. In 2007, however, a significant outbreak of Zika virus (ZIKV) was reported on the island of Yap and the virus has recently been responsible for major outbreaks of disease in French Polynesia in […]

Oropouche virus nucleoprotein

Oropouche Virus – an emerging public health challenge in tropical and subtropical areas of Central and South America

March 14th, 2017

  In 2016, the World Health Organization (WHO) reported the first outbreak of Oropouche fever in the Northern part of the Cusco region of Peru, resulting in 57 reported cases of infection due to the Oropouche virus (OROV). Oropouche virus (OROV) is an RNA virus that belongs to the family Bunyaviridae. Phylogenetic analysis of OROV […]

Newsletter January 2017

January 25th, 2017

Our Newsletter from January 2017 includes updates on new products and services, including those summarised below. Read the full newsletter for all the details. Recombinant Envelope Proteins for Zika and Dengue Viruses We have developed recombinant envelope proteins from Zika and Dengue viruses to complement our range of NS1 proteins. These proteins will provide researchers […]

Dengue virus NS1

Dengue virus NS1 aids transfer into host mosquitoes

July 6th, 2016

Dengue virus NS1 proteins aid viral transfer into host mosquitoes   In a publication in Nature Microbiology (June 2016) Liu et al have demonstrated that Dengue virus NS1 protein has an important role to play in infecting the mosquitoes that act as vectors for Dengue virus infection. It seems that the Dengue virus NS1 protein […]

Zika Virus NS1 antigen used to generate Zika specific binders by Avacta

June 27th, 2016

The value of the Zika Virus NS1 antigen manufactured by The Native Antigen Company for the development of diagnostic assays and reagents has been demonstrated by the announcement from Avacta Life Sciences that they have used Zika Virus NS1 antigen to prepare Zika virus specific affimers. The Native Antigen Company Zika Virus NS1 antigen was […]